A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers. (4th November 2015) - Lu, Yong-Chen; Parker, Linda; Lu, Tangying; Zheng, Zhili; Yao, Xin; Robbins, Paul F; van der Bruggen, Pierre; Klebanoff, Christopher A; Hinrichs, Christian S; Goff, Stephanie; Sherry, Richard; Kammula, Udai; et al.